Form 8-K dated January 7, 2003
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of
earliest event reported) January 7, 2003
Targeted Genetics Corporation
(Exact name of registrant as specified in charter)
| Washington |
|
0-23930 |
|
91-1549568 |
| (State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
| 1100 Olive Way, Suite 100, Seattle, Washington |
|
98101 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code (206) 623-7612
Not Applicable
(Former name or former address, if changed since last report)
Item 5. Other Events.
On January 7, 2003, Targeted Genetics Corporation announced that listing of its common stock will be transferred from the Nasdaq National
Market to the Nasdaq SmallCap Market as of market opening on January 8, 2003. The text of the press release is set forth in Exhibit 99.1 attached to this release and incorporated herein by this reference.
Item 7. Exhibits.
| |
(a) |
|
Financial statements of business acquired. |
Not applicable.
| |
(b) |
|
Pro forma financial information. |
Not applicable.
| Exhibit No.
|
|
Description
|
| |
| 99.1 |
|
Press Release dated January 7, 2003 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
|
TARGETED GENETICS CORPORATION |
| |
| Date: January 8, 2003 |
|
|
|
By: |
|
/S/ TODD E. SIMPSON
|
| |
|
|
|
|
|
Todd E. Simpson Vice President, Finance and Administration and Chief Financial
Officer, Secretary and Treasurer (Principal Financial and Accounting Officer) |
EXHIBIT INDEX
| Exhibit No.
|
|
Description
|
| |
| 99.1 |
|
Press Release dated January 7, 2003 |